Authors:
Gilbert, R
Dunn, D
Wallon, M
Hayde, M
Prusa, A
Lebech, M
Kortbeek, T
Peyron, F
Pollak, A
Petersen, E
Citation: R. Gilbert et al., Ecological comparison of the risks of mother-to-child transmission and clinical manifestations of congenital toxoplasmosis according to prenatal treatment protocol, EPIDEM INFE, 127(1), 2001, pp. 113-120
Authors:
Romand, S
Wallon, M
Franck, J
Thulliez, P
Peyron, F
Dumon, H
Citation: S. Romand et al., Prenatal diagnosis using polymerase chain reaction on amniotic fluid for congenital toxoplasmosis, OBSTET GYN, 97(2), 2001, pp. 296-300
Citation: M. Wallon et al., Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy, BR MED J, 318(7197), 1999, pp. 1511-1514
Authors:
Wallon, M
Dunn, D
Slimani, D
Girault, V
Gay-Andrieu, F
Peyron, F
Citation: M. Wallon et al., Diagnosis of congenital toxoplasmosis at birth: what is the value of testing for IgM and IgA?, EUR J PED, 158(8), 1999, pp. 645-649
Authors:
Dunn, D
Wallon, M
Peyron, F
Petersen, E
Peckham, C
Gilbert, R
Citation: D. Dunn et al., Mother-to-child transmission of toxoplasmosis: risk estimates for clinicalcounselling, LANCET, 353(9167), 1999, pp. 1829-1833
Authors:
Kahi, S
Cozon, GJN
Pinon, JM
Greenland, T
Wallon, M
Al Kurdi, M
Ferrandiz, J
Peyron, F
Citation: S. Kahi et al., A switch towards Th2 during serological rebound in children with congenital toxoplasmosis, CLIN EXP IM, 117(3), 1999, pp. 524-528